Texts for Diabetes Control Among Homeless Persons

Sponsor
George Washington University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05616026
Collaborator
(none)
100
1
2
23
4.3

Study Details

Study Description

Brief Summary

This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods to assess the impact of a SMS text strategy in diabetes control among persons who experience homelessness.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention
  • Behavioral: Attention Control
N/A

Detailed Description

Diabetes mellitus (DM) is common among persons experiencing homelessness (PEH), often inadequately managed, and carries significant costs. SMS strategies for DM have not been tested among PEH despite the accessibility of mobile phones. This study uses a SMS strategy to offer better communication, education, and information management; improve outreach; facilitate care coordination; explore barriers to care; and support behavior changes. This mixed-methods (RCT and qualitative) study will be implemented in shelter-clinics in New York City in collaboration with community organizations, allowing for sustainability and scalability. Aim 1 will evaluate the efficacy of a 6-month SMS program for DM management versus an attention control on changes in HbA1c and adherence to DM self-care activities, medications, and appointments at 9 months in adult PEH with uncontrolled DM (n=100). Outcomes will be measured at 0, 3, 6, &9 months. Aim 2 will assess patients' and providers' attitudes, acceptability, and experience of the program through semi-structured interviews with PEH and providers.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Intervention versus Control group; Randomized at the Individual levelIntervention versus Control group; Randomized at the Individual level
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Short-messaging Services (SMS) Text for Uncontrolled Diabetes Among Persons Experiencing Homelessness
Anticipated Study Start Date :
Dec 15, 2022
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
Nov 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The intervention (INT) will include 6 months of DM management support via SMS texts including reminders for medication adherence, appointments, and DM self-care activities as well as education, and support.

Behavioral: Intervention
6 months of diabetes management support via SMS texts including reminders for medication adherence, appointments, and diabetes self-care activities as well as education, and support
Other Names:
  • Diabetes SMS text
  • Placebo Comparator: Control

    The control (CL) will receive 6 months of texts for general health promotion.

    Behavioral: Attention Control
    6 months of texts for general health promotion

    Outcome Measures

    Primary Outcome Measures

    1. Change in HbA1c [9 months]

      Hemoglobin A1c level

    Secondary Outcome Measures

    1. Summary of Diabetes Self-Care Activities (SDSCA) [9 months]

      Summary of Diabetes Self-Care Activities

    2. Proportion of Days Covered (PDC) [9 months]

      Medication Adherence through Proportion of Days Covered of Medications

    3. Appointment Adherence [9 months]

      Proportion of appointment adherence

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Homeless person age ≥ 21

    • Diagnosed with type 2 DM

    • Most recent visit HbA1c ≥ 8%

    • English/Spanish speaking

    • Connected to study sites' shelter-clinics for care

    Exclusion Criteria:
    • Pregnant or within 3 months postpartum

    • Has an uncontrolled severe illness

    • Has had a heart attack or stroke in the previous 6 months

    • Inability to read/respond to texts

    • Inability to provide informed consent

    • Receiving inpatient care for severe substance abuse

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 George Washington University Washington District of Columbia United States 20052

    Sponsors and Collaborators

    • George Washington University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ramin Asgary, Associate Professor School oh Public Health, PI, George Washington University
    ClinicalTrials.gov Identifier:
    NCT05616026
    Other Study ID Numbers:
    • #11-21-ICTSHD-16
    First Posted:
    Nov 14, 2022
    Last Update Posted:
    Nov 14, 2022
    Last Verified:
    Nov 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ramin Asgary, Associate Professor School oh Public Health, PI, George Washington University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 14, 2022